Consecutive Sales Growth Streak
Seven consecutive quarters of year-over-year sales growth; consolidated Q3 net sales of $55.5M versus $53.8M prior year (+3.1% YoY). Excluding the divested healthcare business, net sales increased by 6.0%.
PMT Segment Momentum
PMT sales grew meaningfully: reported at ~$38.7M (CFO noted PMT led with a 9.7% increase; excluding legacy healthcare PMT net sales rose 14.5%), driven by semiconductor wafer fab demand and RF/microwave components (satcom, radar).
Return to Profitability and Improved Margins
Operating income improved to $1.5M in Q3 from an operating loss of $2.7M a year earlier; consolidated gross margin rose to 31.9% from 31.0% (+90 basis points). Net income was $0.9M versus a $2.1M loss prior year.
EBITDA Turnaround
Reported EBITDA for Q3 was $2.2M versus negative $2.1M in prior-year quarter, reflecting improved operating performance and margin discipline.
Strong Backlog and Order Activity
Total backlog increased to $151.2M at quarter end. PMT backlog reported at $75.4M and Canvas backlog at $38.2M; GES backlog near $40M with core PEM backlog up 15% in Q3 and YTD bookings for key GES products in the high double digits versus prior year.
Cash, Balance Sheet and Dividend
Cash and cash equivalents of $29.5M at quarter end; no outstanding debt on the revolving credit facility. Board declared a regular quarterly cash dividend of $0.06 per common share (paid $0.9M in Q3).
New Product Wins and Program Progress
GES booked its first BES program in Q3 (began shipping in Q4); multiple new PEM and accessory products progressing (orders from Brazil, Australia, India, France, Italy). PMT shipped first system (~$570k) and reported sustained semi fab demand optimism for FY27.
Canvas Profitability and Pipeline
Canvas remained profitable with a Q3 gross margin of 32.2% and backlog of $38.2M; year-to-date revenues increased to $25.0M from $23.7M despite quarter-over-quarter project timing variability.